We were delighted to be joined by Ola Włodek, a biotech executive and the CEO of Constructive Bio, a company at the forefront of synthetic biology and the development of new ways to engineer biology and create novel molecules.

Ola brings a wealth of experience across the life sciences industry, with a background spanning strategy, operations, and business leadership. At Constructive Bio, she is part of the team working to translate cutting-edge synthetic biology into a platform capable of creating entirely new possibilities for drug discovery and development.

In today’s conversation, we’ll explore Ola’s career journey, and the potential of the company’s technology to fundamentally change how we think about designing and developing new medicines. We’ll also discuss the challenges of scaling a highly innovative biotech, the next major inflection points for the business, and Ola’s perspective on where the industry is heading.

Podden och tillhörande omslagsbild på den här sidan tillhör Max Brennan - Biotech HeadHunter. Innehållet i podden är skapat av Max Brennan - Biotech HeadHunter och inte av, eller tillsammans med, Poddtoppen.